Today’s guest post comes from Sean Wagner, VP of Client Partnerships and Carolyn Zele, Advisor, Solution Consulting at MMIT.
Sean and Carolyn argue that planning for a successful drug launch must begin early—often well before Phase III. In this article, they present a six-step framework to help manufacturers align clinical development with payer expectations, patient needs, and real-world access dynamics.
To learn more, view their latest webinar: Meet the Expert: Developing Your Commercial Strategy in Phases II-III.
Read on for Sean and Carolyn’s insights.
Read more »
